Evidence map›Paper›PMID 42238817›Full record

ArticleFrontiers in genetics2026

mRNALocator-imb: an imbalance-tolerant ensemble framework integrating random forest and transformer for mRNA subcellular localization prediction.

Jinbo Hu, Haibin Liu, Lanzhong Wang, Hao Wu

Abstract read
In one paragraph

Article in Frontiers in genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jinbo HuSchool of Airspace Science and Engineering, Shandong University, Weihai, Shandong, China.
Haibin LiuSchool of Software, Shandong University, Jinan, Shandong, China.
Lanzhong WangSchool of Foreign Languages and Literature, Shandong University, Jinan, Shandong, China.
Hao WuSchool of Software, Shandong University, Jinan, Shandong, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The subcellular localization of mRNAs determines the spatial context of protein translation and plays a critical role in the precise regulation of protein function. However, existing computational approaches for predicting eukaryotic mRNA localization are often limited by inadequate exploitation of sequence-derived information and suboptimal performance under highly imbalanced data distributions. To address these challenges, we propose mRNALocator-imb, an imbalance-aware ensemble framework for mRNA subcellular localization prediction. The proposed model integrates physicochemical property-based features with k-mer frequency vectors, and adopts a hybrid architecture that combines Random Forest and Transformer networks to capture both global sequence patterns and contextual dependencies. To explicitly mitigate class imbalance, Random Oversampling and Label-Distribution-Aware Margin (LDAM) loss are incorporated during Transformer training, while the Synthetic Minority Over-sampling Technique (SMOTE) is employed to rebalance the data for Random Forest learning. Extensive experiments demonstrate that mRNALocator-imb consistently outperforms conventional machine learning methods and state-of-the-art predictors, particularly in scenarios characterized by severe class imbalance. Overall, this study presents a robust and generalizable framework for sequence-based subcellular localization prediction, with broad applicability to other imbalanced learning problems in bioinformatics.

Indexed as

adaptive synthetic samplingdeep learning frameworksimbalanced datasetlabel-distribution-aware marginmRNA subcellular localization

Identifiers

PMID42238817
PMCPMC13229483

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.